ACCP collaborates with ASHP on Oncology Pharmacy activities.
Pre-Sale Date: February 22, 2023
Volume 1
Release Date: March 22, 2023
BCOP credit expiration date: September 26, 2023
ACPE expiration date: March 22, 2026
Volume 2
Release Date: September 13, 2023
BCOP credit expiration date: September 10, 2024
ACPE expiration date: September 13, 2026
Offered twice a year the Oncology Pharmacy Specialty Home Study Syllabus for Recertification consists of a collection of journal articles that focuses on advances across the four domains of oncology specialty practice. The Home Study Syllabus is intended for board certified oncology pharmacists (BCOPs) in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Each module consists of 2 online home study activities (see topics below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.
Learners will be required to review the content of the articles and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this course, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ACCP and ASHP professional development program for BCOP recertification approved by the BPS.
The first volume will be released on March 22, 2023 and the second volume is scheduled to be released September 13, 2023. Each volume will offer at least eight hours of BCOP recertification credit.
Volume 1 – Released March 2023
Topics in Volume 1 include:
- Pharmacogenomics
- Statistics
- Pediatric Malignancy
- Hepatocellular Carcinoma
- Urothelial Carcinoma
- Pharmacy Practice Management
- Lymphoma
Volume 2 – Released September 2023
Topics in Volume 2 include:
- Hematopoietic Cell Transplantation
- Prostate Cancer
- Pancreatic Cancer
- Breast Cancer
- Chronic Leukemia
- Gynecologic Malignancies
- Lung Cancer
Two Volume Package –
Access to Articles and Online Posttests with Continuing Pharmacy Education/Recertification Credit
Includes access to articles for Volume 1 (March release) and Volume 2 (September release) and online posttests for recertification credit.
Recertification Expires: Volume 1: September 26, 2023
ACPE Expires: Volume 1: March 22, 2026
Recertification Expires: Volume 2: September 10, 2024
ACPE Expires: Volume 2: September 13, 2026
Price: $425.00
Member: $295.00
|
Volume 1 – March Release
Access to Articles and Online Posttests with Continuing Pharmacy Education/Recertification Credit
Includes access to articles for Volume 1 (March release) and online posttests for recertification credit.
Recertification Expires: Volume 1: September 26, 2023
ACPE Expires: Volume 1: March 22, 2026
Price: $215.00
Member: $160.00
|
Volume 2 – September Release
Access to Articles and Online Posttests with Continuing Pharmacy Education/Recertification Credit
Includes access to articles for Volume 2 (September release) and online posttests for recertification credit.
Recertification Expires: Volume 2: September 10, 2024
ACPE Expires: Volume 2: September 13, 2026
Price: $215.00
Member: $160.00
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
2023 Oncology Pharmacy Specialty Home Study Syllabus for Recertification, Volume 1
- Oncology Home Study Syllabus Module 1A: Pharmacogenomics, Statistics, Pediatric Malignancy
Universal Activity Number: 0204-9999-23-952-H01-P
4.0 contact hours
- Oncology Home Study Syllabus Module 1B: Hepatocellular Carcinoma, Urothelial Carcinoma, Pharmacy Practice Management, Lymphoma
Universal Activity Number: 0204-9999-23-953-H01-P
4.0 contact hours
2023 Oncology Pharmacy Specialty Home Study Syllabus for Recertification, Volume 2
- Oncology Home Study Syllabus Module 2A: Hematopoietic Cell Transplantation, Prostate Cancer, Pancreatic Cancer
Universal Activity Number: 0204-9999-23-980-H01-P
4.0 contact hours
- Oncology Home Study Syllabus Module 2B: Breast Cancer, Chronic Leukemia, Gynecologic Malignancies, Lung Cancer
Universal Activity Number: 0204-9999-23-981-H01-P
4.0 contact hours
All continuing pharmacy education activities associated with the 2023 Oncology Pharmacy Specialty Home Study Syllabus for Recertification are application-based activities.
Methods and CE Requirements
Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, learners must purchase the product, review all content, successfully complete, submit and pass the web-based posttests associated with Volume 1 by March 22, 2026, and Volume 2 by September 13, 2026. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
National Association of Boards of Pharmacy - CPE Monitor Service
Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.
To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.
Board certified pharmacists are eligible to receive up to 8.0 hours of recertification credit for completing each volume. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by September 26, 2023 for Volume 1 and September 10, 2024 for Volume 2. These credits will be assigned as of the date of test submission. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
For statements of recertification credit, visit www.bpsweb.org. Questions regarding the number of hours required for BCOP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs.
|
John Bossaer, Pharm.D., BCOP
Professor
East Tennessee State University
Bill Gatton College of Pharmacy
Johnson City, Tennessee |
|
Courtney C. Cavalieri, Pharm.D., BCOP*
Clinical Oncology Pharmacist
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah |
|
Brette Conliffe, Pharm.D., BCOP
Clinical Oncology Supervisor
University of Louisville Health/Brown Cancer Center
Louisville, Kentucky |
|
Karen M. Fancher, Pharm.D., BCOP*
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist – Oncology
University of Pittsburgh Medical Center Passavant Hospital
Pittsburgh, Pennsylvania |
|
Christopher Fausel, Pharm.D., M.H.A., BCOP
Director of Pharmacy - Precision Genomics
Indiana University Health
Indianapolis, Indiana |
|
Lauren Ice, Pharm.D., BCOP, BCPS
Clinical Pharmacy Specialist
Corewell Health
Grand Rapids, Michigan |
|
Alexis R. Jones, Pharm.D., BCOP, CPP
Clinical Pharmacist, Gynecologic Oncology
University of North Carolina Medical Center
Chapel Hill, North Carolina |
|
Elyse A. MacDonald, Pharm.D., M.S., BCPS
Director, Pharmacy Services, Investigational Drug Service
Stanford Health Care
Palo Alto, California |
|
Janelle Mann, Pharm.D., BCOP
Manager of Clinical Pharmacy Services
Alvin J. Siteman Cancer Center
Clinical Oncology Pharmacist
Washington University School of Medicine
St. Louis, Missouri |
|
Anthony J. Perissinotti, Pharm.D., BCOP*
Hematology Clinical Pharmacist Specialist
University of Michigan
Ann Arbor, Michigan |
|
Danielle Roman, Pharm.D., BCOP
Manager, Oncology Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania |
|
Christine M. Walko, Pharm.D., BCOP, FCCP*
Senior Member, Individualized Cancer Management;
Precision Medicine Program Lead
H. Lee Moffitt Cancer Center
Tampa, Florida |
|
Jennifer Young, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Hematology / Oncology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio |